A higher plasma fetuin-A concentration was associated with better cognitive performance in patients with mild-to-moderate Alzheimer’s disease [55], and higher fetuin-A was associated with a lower risk of cognitive decline during follow-up for 4 years in community-dwelling older adults [56]. Here, AHSG is linked to early-onset autosomal dominant Alzheimer disease.